Ocular drug delivery system designed to treat eye locally, whereas the conventional method of drug delivery is less effective due to the presence of various barriers.

The global Ocular Drug Delivery System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery System.

Report Scope

The Ocular Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ocular Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ocular Drug Delivery System Market Report

Report Metric	Details
Report Name	Ocular Drug Delivery System Market
CAGR	5%
Segment by Type	Implantable Ocular Drug Delivery Systems Particulate Drug Delivery Systems
Segment by Application	Hospitals Clinics Ambulatory Surgical Centers
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ocular Therapeutix, Alimera Sciences, Allergan, Graybug Vision, Bausch Health, EyePoint Pharmaceuticals, Santen Pharmaceutical, Taiwan Liposome, Envisia Therapeutics, Clearside Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ocular Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ocular Drug Delivery System Market report?

Ans: The main players in the Ocular Drug Delivery System Market are Ocular Therapeutix, Alimera Sciences, Allergan, Graybug Vision, Bausch Health, EyePoint Pharmaceuticals, Santen Pharmaceutical, Taiwan Liposome, Envisia Therapeutics, Clearside Biomedical

What are the Application segmentation covered in the Ocular Drug Delivery System Market report?

Ans: The Applications covered in the Ocular Drug Delivery System Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Ocular Drug Delivery System Market report?

Ans: The Types covered in the Ocular Drug Delivery System Market report are Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems

1 Ocular Drug Delivery System Market Overview

1.1 Product Overview and Scope of Ocular Drug Delivery System

1.2 Ocular Drug Delivery System Segment by Type

1.2.1 Global Ocular Drug Delivery System Market Value Comparison by Type (2024-2030)

1.2.2 Implantable Ocular Drug Delivery Systems

1.2.3 Particulate Drug Delivery Systems

1.3 Ocular Drug Delivery System Segment by Application

1.3.1 Global Ocular Drug Delivery System Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Global Ocular Drug Delivery System Market Size Estimates and Forecasts

1.4.1 Global Ocular Drug Delivery System Revenue 2019-2030

1.4.2 Global Ocular Drug Delivery System Sales 2019-2030

1.4.3 Global Ocular Drug Delivery System Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Ocular Drug Delivery System Market Competition by Manufacturers

2.1 Global Ocular Drug Delivery System Sales Market Share by Manufacturers (2019-2024)

2.2 Global Ocular Drug Delivery System Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Ocular Drug Delivery System Average Price by Manufacturers (2019-2024)

2.4 Global Ocular Drug Delivery System Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ocular Drug Delivery System, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ocular Drug Delivery System, Product Type & Application

2.7 Ocular Drug Delivery System Market Competitive Situation and Trends

2.7.1 Ocular Drug Delivery System Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Ocular Drug Delivery System Players Market Share by Revenue

2.7.3 Global Ocular Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ocular Drug Delivery System Retrospective Market Scenario by Region

3.1 Global Ocular Drug Delivery System Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Ocular Drug Delivery System Global Ocular Drug Delivery System Sales by Region: 2019-2030

3.2.1 Global Ocular Drug Delivery System Sales by Region: 2019-2024

3.2.2 Global Ocular Drug Delivery System Sales by Region: 2025-2030

3.3 Global Ocular Drug Delivery System Global Ocular Drug Delivery System Revenue by Region: 2019-2030

3.3.1 Global Ocular Drug Delivery System Revenue by Region: 2019-2024

3.3.2 Global Ocular Drug Delivery System Revenue by Region: 2025-2030

3.4 North America Ocular Drug Delivery System Market Facts & Figures by Country

3.4.1 North America Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Ocular Drug Delivery System Sales by Country (2019-2030)

3.4.3 North America Ocular Drug Delivery System Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Ocular Drug Delivery System Market Facts & Figures by Country

3.5.1 Europe Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Ocular Drug Delivery System Sales by Country (2019-2030)

3.5.3 Europe Ocular Drug Delivery System Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ocular Drug Delivery System Market Facts & Figures by Country

3.6.1 Asia Pacific Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Ocular Drug Delivery System Sales by Country (2019-2030)

3.6.3 Asia Pacific Ocular Drug Delivery System Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Ocular Drug Delivery System Market Facts & Figures by Country

3.7.1 Latin America Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Ocular Drug Delivery System Sales by Country (2019-2030)

3.7.3 Latin America Ocular Drug Delivery System Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ocular Drug Delivery System Market Facts & Figures by Country

3.8.1 Middle East and Africa Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Ocular Drug Delivery System Sales by Country (2019-2030)

3.8.3 Middle East and Africa Ocular Drug Delivery System Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ocular Drug Delivery System Sales by Type (2019-2030)

4.1.1 Global Ocular Drug Delivery System Sales by Type (2019-2024)

4.1.2 Global Ocular Drug Delivery System Sales by Type (2025-2030)

4.1.3 Global Ocular Drug Delivery System Sales Market Share by Type (2019-2030)

4.2 Global Ocular Drug Delivery System Revenue by Type (2019-2030)

4.2.1 Global Ocular Drug Delivery System Revenue by Type (2019-2024)

4.2.2 Global Ocular Drug Delivery System Revenue by Type (2025-2030)

4.2.3 Global Ocular Drug Delivery System Revenue Market Share by Type (2019-2030)

4.3 Global Ocular Drug Delivery System Price by Type (2019-2030)

5 Segment by Application

5.1 Global Ocular Drug Delivery System Sales by Application (2019-2030)

5.1.1 Global Ocular Drug Delivery System Sales by Application (2019-2024)

5.1.2 Global Ocular Drug Delivery System Sales by Application (2025-2030)

5.1.3 Global Ocular Drug Delivery System Sales Market Share by Application (2019-2030)

5.2 Global Ocular Drug Delivery System Revenue by Application (2019-2030)

5.2.1 Global Ocular Drug Delivery System Revenue by Application (2019-2024)

5.2.2 Global Ocular Drug Delivery System Revenue by Application (2025-2030)

5.2.3 Global Ocular Drug Delivery System Revenue Market Share by Application (2019-2030)

5.3 Global Ocular Drug Delivery System Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Ocular Therapeutix

6.1.1 Ocular Therapeutix Corporation Information

6.1.2 Ocular Therapeutix Description and Business Overview

6.1.3 Ocular Therapeutix Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Ocular Therapeutix Ocular Drug Delivery System Product Portfolio

6.1.5 Ocular Therapeutix Recent Developments/Updates

6.2 Alimera Sciences

6.2.1 Alimera Sciences Corporation Information

6.2.2 Alimera Sciences Description and Business Overview

6.2.3 Alimera Sciences Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Alimera Sciences Ocular Drug Delivery System Product Portfolio

6.2.5 Alimera Sciences Recent Developments/Updates

6.3 Allergan

6.3.1 Allergan Corporation Information

6.3.2 Allergan Description and Business Overview

6.3.3 Allergan Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Allergan Ocular Drug Delivery System Product Portfolio

6.3.5 Allergan Recent Developments/Updates

6.4 Graybug Vision

6.4.1 Graybug Vision Corporation Information

6.4.2 Graybug Vision Description and Business Overview

6.4.3 Graybug Vision Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Graybug Vision Ocular Drug Delivery System Product Portfolio

6.4.5 Graybug Vision Recent Developments/Updates

6.5 Bausch Health

6.5.1 Bausch Health Corporation Information

6.5.2 Bausch Health Description and Business Overview

6.5.3 Bausch Health Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bausch Health Ocular Drug Delivery System Product Portfolio

6.5.5 Bausch Health Recent Developments/Updates

6.6 EyePoint Pharmaceuticals

6.6.1 EyePoint Pharmaceuticals Corporation Information

6.6.2 EyePoint Pharmaceuticals Description and Business Overview

6.6.3 EyePoint Pharmaceuticals Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.6.4 EyePoint Pharmaceuticals Ocular Drug Delivery System Product Portfolio

6.6.5 EyePoint Pharmaceuticals Recent Developments/Updates

6.7 Santen Pharmaceutical

6.6.1 Santen Pharmaceutical Corporation Information

6.6.2 Santen Pharmaceutical Description and Business Overview

6.6.3 Santen Pharmaceutical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Santen Pharmaceutical Ocular Drug Delivery System Product Portfolio

6.7.5 Santen Pharmaceutical Recent Developments/Updates

6.8 Taiwan Liposome

6.8.1 Taiwan Liposome Corporation Information

6.8.2 Taiwan Liposome Description and Business Overview

6.8.3 Taiwan Liposome Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Taiwan Liposome Ocular Drug Delivery System Product Portfolio

6.8.5 Taiwan Liposome Recent Developments/Updates

6.9 Envisia Therapeutics

6.9.1 Envisia Therapeutics Corporation Information

6.9.2 Envisia Therapeutics Description and Business Overview

6.9.3 Envisia Therapeutics Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Envisia Therapeutics Ocular Drug Delivery System Product Portfolio

6.9.5 Envisia Therapeutics Recent Developments/Updates

6.10 Clearside Biomedical

6.10.1 Clearside Biomedical Corporation Information

6.10.2 Clearside Biomedical Description and Business Overview

6.10.3 Clearside Biomedical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Clearside Biomedical Ocular Drug Delivery System Product Portfolio

6.10.5 Clearside Biomedical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ocular Drug Delivery System Industry Chain Analysis

7.2 Ocular Drug Delivery System Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ocular Drug Delivery System Production Mode & Process

7.4 Ocular Drug Delivery System Sales and Marketing

7.4.1 Ocular Drug Delivery System Sales Channels

7.4.2 Ocular Drug Delivery System Distributors

7.5 Ocular Drug Delivery System Customers

8 Ocular Drug Delivery System Market Dynamics

8.1 Ocular Drug Delivery System Industry Trends

8.2 Ocular Drug Delivery System Market Drivers

8.3 Ocular Drug Delivery System Market Challenges

8.4 Ocular Drug Delivery System Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eyepoint Pharmaceuticals

Santen Pharmaceutical

Taiwan Liposome

Envisia Therapeutics

Clearside Biomedical

List of Tables

Table 1. Global Ocular Drug Delivery System Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Ocular Drug Delivery System Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Ocular Drug Delivery System Market Competitive Situation by Manufacturers in 2023

Table 4. Global Ocular Drug Delivery System Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Ocular Drug Delivery System Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Ocular Drug Delivery System Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Ocular Drug Delivery System Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Ocular Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Ocular Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ocular Drug Delivery System, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ocular Drug Delivery System, Product Type & Application

Table 12. Global Key Manufacturers of Ocular Drug Delivery System, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ocular Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery System as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ocular Drug Delivery System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Ocular Drug Delivery System Sales by Region (2019-2024) & (K Units)

Table 18. Global Ocular Drug Delivery System Sales Market Share by Region (2019-2024)

Table 19. Global Ocular Drug Delivery System Sales by Region (2025-2030) & (K Units)

Table 20. Global Ocular Drug Delivery System Sales Market Share by Region (2025-2030)

Table 21. Global Ocular Drug Delivery System Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Ocular Drug Delivery System Revenue Market Share by Region (2019-2024)

Table 23. Global Ocular Drug Delivery System Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Ocular Drug Delivery System Revenue Market Share by Region (2025-2030)

Table 25. North America Ocular Drug Delivery System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Ocular Drug Delivery System Sales by Country (2019-2024) & (K Units)

Table 27. North America Ocular Drug Delivery System Sales by Country (2025-2030) & (K Units)

Table 28. North America Ocular Drug Delivery System Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Ocular Drug Delivery System Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Ocular Drug Delivery System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Ocular Drug Delivery System Sales by Country (2019-2024) & (K Units)

Table 32. Europe Ocular Drug Delivery System Sales by Country (2025-2030) & (K Units)

Table 33. Europe Ocular Drug Delivery System Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Ocular Drug Delivery System Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Ocular Drug Delivery System Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Ocular Drug Delivery System Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Ocular Drug Delivery System Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Ocular Drug Delivery System Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Ocular Drug Delivery System Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Ocular Drug Delivery System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Ocular Drug Delivery System Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Ocular Drug Delivery System Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Ocular Drug Delivery System Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Ocular Drug Delivery System Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Ocular Drug Delivery System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Ocular Drug Delivery System Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Ocular Drug Delivery System Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Ocular Drug Delivery System Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Ocular Drug Delivery System Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Ocular Drug Delivery System Sales (K Units) by Type (2019-2024)

Table 51. Global Ocular Drug Delivery System Sales (K Units) by Type (2025-2030)

Table 52. Global Ocular Drug Delivery System Sales Market Share by Type (2019-2024)

Table 53. Global Ocular Drug Delivery System Sales Market Share by Type (2025-2030)

Table 54. Global Ocular Drug Delivery System Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Ocular Drug Delivery System Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Ocular Drug Delivery System Revenue Market Share by Type (2019-2024)

Table 57. Global Ocular Drug Delivery System Revenue Market Share by Type (2025-2030)

Table 58. Global Ocular Drug Delivery System Price (US$/Unit) by Type (2019-2024)

Table 59. Global Ocular Drug Delivery System Price (US$/Unit) by Type (2025-2030)

Table 60. Global Ocular Drug Delivery System Sales (K Units) by Application (2019-2024)

Table 61. Global Ocular Drug Delivery System Sales (K Units) by Application (2025-2030)

Table 62. Global Ocular Drug Delivery System Sales Market Share by Application (2019-2024)

Table 63. Global Ocular Drug Delivery System Sales Market Share by Application (2025-2030)

Table 64. Global Ocular Drug Delivery System Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Ocular Drug Delivery System Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Ocular Drug Delivery System Revenue Market Share by Application (2019-2024)

Table 67. Global Ocular Drug Delivery System Revenue Market Share by Application (2025-2030)

Table 68. Global Ocular Drug Delivery System Price (US$/Unit) by Application (2019-2024)

Table 69. Global Ocular Drug Delivery System Price (US$/Unit) by Application (2025-2030)

Table 70. Ocular Therapeutix Corporation Information

Table 71. Ocular Therapeutix Description and Business Overview

Table 72. Ocular Therapeutix Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Ocular Therapeutix Ocular Drug Delivery System Product

Table 74. Ocular Therapeutix Recent Developments/Updates

Table 75. Alimera Sciences Corporation Information

Table 76. Alimera Sciences Description and Business Overview

Table 77. Alimera Sciences Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Alimera Sciences Ocular Drug Delivery System Product

Table 79. Alimera Sciences Recent Developments/Updates

Table 80. Allergan Corporation Information

Table 81. Allergan Description and Business Overview

Table 82. Allergan Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Allergan Ocular Drug Delivery System Product

Table 84. Allergan Recent Developments/Updates

Table 85. Graybug Vision Corporation Information

Table 86. Graybug Vision Description and Business Overview

Table 87. Graybug Vision Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Graybug Vision Ocular Drug Delivery System Product

Table 89. Graybug Vision Recent Developments/Updates

Table 90. Bausch Health Corporation Information

Table 91. Bausch Health Description and Business Overview

Table 92. Bausch Health Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Bausch Health Ocular Drug Delivery System Product

Table 94. Bausch Health Recent Developments/Updates

Table 95. EyePoint Pharmaceuticals Corporation Information

Table 96. EyePoint Pharmaceuticals Description and Business Overview

Table 97. EyePoint Pharmaceuticals Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. EyePoint Pharmaceuticals Ocular Drug Delivery System Product

Table 99. EyePoint Pharmaceuticals Recent Developments/Updates

Table 100. Santen Pharmaceutical Corporation Information

Table 101. Santen Pharmaceutical Description and Business Overview

Table 102. Santen Pharmaceutical Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Santen Pharmaceutical Ocular Drug Delivery System Product

Table 104. Santen Pharmaceutical Recent Developments/Updates

Table 105. Taiwan Liposome Corporation Information

Table 106. Taiwan Liposome Description and Business Overview

Table 107. Taiwan Liposome Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Taiwan Liposome Ocular Drug Delivery System Product

Table 109. Taiwan Liposome Recent Developments/Updates

Table 110. Envisia Therapeutics Corporation Information

Table 111. Envisia Therapeutics Description and Business Overview

Table 112. Envisia Therapeutics Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Envisia Therapeutics Ocular Drug Delivery System Product

Table 114. Envisia Therapeutics Recent Developments/Updates

Table 115. Clearside Biomedical Corporation Information

Table 116. Clearside Biomedical Description and Business Overview

Table 117. Clearside Biomedical Ocular Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Clearside Biomedical Ocular Drug Delivery System Product

Table 119. Clearside Biomedical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Ocular Drug Delivery System Distributors List

Table 123. Ocular Drug Delivery System Customers List

Table 124. Ocular Drug Delivery System Market Trends

Table 125. Ocular Drug Delivery System Market Drivers

Table 126. Ocular Drug Delivery System Market Challenges

Table 127. Ocular Drug Delivery System Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Ocular Drug Delivery System

Figure 2. Global Ocular Drug Delivery System Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Ocular Drug Delivery System Market Share by Type in 2023 & 2030

Figure 4. Implantable Ocular Drug Delivery Systems Product Picture

Figure 5. Particulate Drug Delivery Systems Product Picture

Figure 6. Global Ocular Drug Delivery System Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Ocular Drug Delivery System Market Share by Application in 2023 & 2030

Figure 8. Hospitals

Figure 9. Clinics

Figure 10. Ambulatory Surgical Centers

Figure 11. Global Ocular Drug Delivery System Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Ocular Drug Delivery System Market Size (2019-2030) & (US$ Million)

Figure 13. Global Ocular Drug Delivery System Sales (2019-2030) & (K Units)

Figure 14. Global Ocular Drug Delivery System Average Price (US$/Unit) & (2019-2030)

Figure 15. Ocular Drug Delivery System Report Years Considered

Figure 16. Ocular Drug Delivery System Sales Share by Manufacturers in 2023

Figure 17. Global Ocular Drug Delivery System Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Ocular Drug Delivery System Players: Market Share by Revenue in 2023

Figure 19. Ocular Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Ocular Drug Delivery System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Ocular Drug Delivery System Sales Market Share by Country (2019-2030)

Figure 22. North America Ocular Drug Delivery System Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Ocular Drug Delivery System Sales Market Share by Country (2019-2030)

Figure 26. Europe Ocular Drug Delivery System Revenue Market Share by Country (2019-2030)

Figure 27. Germany Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Ocular Drug Delivery System Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Ocular Drug Delivery System Revenue Market Share by Region (2019-2030)

Figure 34. China Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Ocular Drug Delivery System Sales Market Share by Country (2019-2030)

Figure 45. Latin America Ocular Drug Delivery System Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Ocular Drug Delivery System Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Ocular Drug Delivery System Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Ocular Drug Delivery System Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Ocular Drug Delivery System by Type (2019-2030)

Figure 55. Global Revenue Market Share of Ocular Drug Delivery System by Type (2019-2030)

Figure 56. Global Ocular Drug Delivery System Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Ocular Drug Delivery System by Application (2019-2030)

Figure 58. Global Revenue Market Share of Ocular Drug Delivery System by Application (2019-2030)

Figure 59. Global Ocular Drug Delivery System Price (US$/Unit) by Application (2019-2030)

Figure 60. Ocular Drug Delivery System Value Chain

Figure 61. Ocular Drug Delivery System Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions